Partnerships with Key Players Enables GWHP Corp To Source PPE Supplies and COVID-19 Diagnostic Testing Kits

Looking for premium PPE supplies and COVID-19 tests during the pandemic? Global WholeHealth Partners is proud to announce that because of our longstanding relationship with key players in the industry, we are able to continually source high quality PPE supplies and COVID-19 diagnostic testing kits in wholesale quantities. As the Delta Variant makes its rounds and cases begin to climb, the continued use of PPE and following social distancing guidelines can help slow the spread of the coronavirus.

As we approach fall of 2021, COVID-19 and the contagious Delta Variant is still affecting the world at large. This is even with social distancing measures and mask mandates back in place in many areas. We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Masks wearing is required in most public indoor places such as shopping malls, grocery stores and restaurants and often times negative COVID-19 tests are required for travel.

GWHP Corp stands committed to sourcing these in demand products and we are hopeful that as more and more people continue to get vaccinated, that we will get ahead of the virus. For more information, simply visit our medical supply page to view our current inventory and get in touch with our specialists to place your wholesale PPE supplies order or wholesale COVID-19 diagnostic testing kits order. We can be reached at 877-568-4947.

About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.